Humanigen, Cenexi Ink Manufacture Pact For COVID-19 Candidate, Lenzilumab, In France Humanigen Inc (NASDAQ: HGEN) has selected Cenexi as a preferred supplier of lenzilumab in France and the European Union. Benzinga · Feb 9, 2022